BioCentury
ARTICLE | Company News

Fournier discloses marketing deals

October 8, 2004 7:00 AM UTC

Laboratoires Fournier (Dijon, France) said its Fournier Pharma division received a license from Recordati (Milan, Italy) to market its Zanidip lercanidipine oral calcium-channel blocker to treat hypertension in Indonesia, Vietnam and other Asian countries. ...